Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Increasing incidence of endometrial carcinoma in a high-risk New Zealand community.

Bigby SM, Tin Tin S, Eva LJ, Shirley P, Dempster-Rivett K, Elwood M.

Aust N Z J Obstet Gynaecol. 2020 Jan 5. doi: 10.1111/ajo.13108. [Epub ahead of print]

PMID:
31903554
2.

Animal studies of exposures to radiofrequency fields.

Elwood M, Wood AW.

N Z Med J. 2019 Nov 8;132(1506):98-100. No abstract available.

PMID:
31778380
3.

Health effects of radiofrequency electromagnetic energy.

Elwood M, Wood AW.

N Z Med J. 2019 Aug 30;132(1501):64-72. Review.

PMID:
31465329
4.

Screening for Anaplastic Lymphoma Kinase (ALK) gene rearrangements in non-small cell lung cancer (NSCLC) in New Zealand.

McKeage MJ, Tin Tin S, Khwaounjoo P, Sheath K, Dixon-McIver A, Ng D, Sullivan R, Cameron L, Shepherd P, Laking GR, Kingston N, Strauss M, Lewis C, Elwood M, Love DR.

Intern Med J. 2019 Jul 18. doi: 10.1111/imj.14435. [Epub ahead of print]

PMID:
31318119
5.

Outcomes in different ethnic groups of New Zealand patients with screen-detected vs. non-screen-detected breast cancer.

Lawrenson R, Lao C, Jacobson G, Seneviratne S, Scott N, Sarfati D, Elwood M, Campbell I.

J Med Screen. 2019 Dec;26(4):197-203. doi: 10.1177/0969141319844801. Epub 2019 May 8. No abstract available.

PMID:
31068074
6.

Mobile phone use and incidence of brain tumour histological types, grading or anatomical location: a population-based ecological study.

Karipidis K, Elwood M, Benke G, Sanagou M, Tjong L, Croft RJ.

BMJ Open. 2018 Dec 9;8(12):e024489. doi: 10.1136/bmjopen-2018-024489. Erratum in: BMJ Open. 2019 Jan 29;9(1):e024489corr1.

7.

Receipt of radiotherapy after mastectomy in women with breast cancer: Population-based cohort study in New Zealand.

Latt PM, Tin Tin S, Elwood M, Lawrenson R, Campbell I.

Asia Pac J Clin Oncol. 2020 Apr;16(2):e99-e107. doi: 10.1111/ajco.13101. Epub 2018 Nov 15.

PMID:
30430744
8.

The impact of different tumour subtypes on management and survival of New Zealand women with Stage I-III breast cancer.

Lawrenson R, Lao C, Campbell I, Harvey V, Seneviratne S, Elwood M, Sarfati D, Kuper-Hommel M.

N Z Med J. 2018 May 18;131(1475):51-60.

PMID:
29771902
9.

The characteristics, management and outcomes of older women with breast cancer in New Zealand.

Blackmore T, Lawrenson R, Lao C, Edwards M, Kuper-Hommel M, Elwood M, Campbell I.

Maturitas. 2018 Jun;112:64-70. doi: 10.1016/j.maturitas.2018.03.018. Epub 2018 Apr 7.

PMID:
29704919
10.

Reply to Crépeaux et al and Blasco.

Ameratunga R, Gillis D, Gold M, Linneberg A, Hawkes D, Langguth D, Elwood M.

J Allergy Clin Immunol Pract. 2018 Mar - Apr;6(2):708-710. doi: 10.1016/j.jaip.2017.11.016. No abstract available.

PMID:
29525003
11.

Ad hominem attacks on vaccine safety researchers.

Ameratunga R, Gillis D, Langguth D, Hawkes D, Linneberg A, Elwood M.

Vaccine. 2018 Jun 22;36(27):3886-3887. doi: 10.1016/j.vaccine.2018.01.053. Epub 2018 Feb 14. No abstract available.

PMID:
29454520
12.

The burden of non-melanoma skin cancers in Auckland, New Zealand.

Pondicherry A, Martin R, Meredith I, Rolfe J, Emanuel P, Elwood M.

Australas J Dermatol. 2018 Aug;59(3):210-213. doi: 10.1111/ajd.12751. Epub 2018 Jan 19.

PMID:
29350397
13.

Characteristics of and differences between Pasifika women and New Zealand European women diagnosed with breast cancer in New Zealand.

Brown C, Lao C, Lawrenson R, Tin Tin S, Schaaf M, Kidd J, Allan-Moetaua A, Herman J, Raamsroop R, Campbell I, Elwood M.

N Z Med J. 2017 Dec 15;130(1467):50-61.

PMID:
29240740
14.

Treatment and survival disparities by ethnicity in New Zealand women with stage I-III breast cancer tumour subtypes.

Lawrenson R, Lao C, Campbell I, Harvey V, Seneviratne S, Edwards M, Elwood M, Scott N, Kidd J, Sarfati D, Kuper-Hommel M.

Cancer Causes Control. 2017 Dec;28(12):1417-1427. doi: 10.1007/s10552-017-0969-9. Epub 2017 Oct 13.

PMID:
29027594
15.
16.

The use of trastuzumab in New Zealand women with breast cancer.

Lawrenson R, Lao C, Campbell I, Harvey V, Brown C, Seneviratne S, Edwards M, Elwood M, Kuper-Hommel M.

Asia Pac J Clin Oncol. 2018 Apr;14(2):e152-e160. doi: 10.1111/ajco.12766. Epub 2017 Aug 30.

PMID:
28856817
17.

EGFR Mutation Testing of non-squamous NSCLC: Impact and Uptake during Implementation of Testing Guidelines in a Population-Based Registry Cohort from Northern New Zealand.

McKeage M, Elwood M, Tin Tin S, Khwaounjoo P, Aye P, Li A, Sheath K, Shepherd P, Laking G, Kingston N, Lewis C, Love D.

Target Oncol. 2017 Oct;12(5):663-675. doi: 10.1007/s11523-017-0515-4.

PMID:
28699084
18.

Screening for lung cancer: Comment on results of de-Torres et al., 2013.

Elwood M.

Respir Med. 2017 May;126:139. doi: 10.1016/j.rmed.2017.02.002. Epub 2017 Feb 11. No abstract available.

19.

Proposed new industry code on unhealthy food marketing to children and young people: will it make a difference?

Swinburn B, Vandevijvere S, Woodward A, Hornblow A, Richardson A, Burlingame B, Borman B, Taylor B, Breier B, Arroll B, Drummond B, Grant C, Bullen C, Wall C, Mhurchu CN, Cameron-Smith D, Menkes D, Murdoch D, Mangin D, Lennon D, Sarfati D, Sellman D, Rush E, Sopoaga F, Thomson G, Devlin G, Abel G, White H, Coad J, Hoek J, Connor J, Krebs J, Douwes J, Mann J, McCall J, Broughton J, Potter JD, Toop L, McCowan L, Signal L, Beckert L, Elwood M, Kruger M, Farella M, Baker M, Keall M, Skeaff M, Thomson M, Wilson N, Chandler N, Reid P, Priest P, Brunton P, Crampton P, Davis P, Gendall P, Howden-Chapman P, Taylor R, Edwards R, Beaglehole R, Doughty R, Scragg R, Gauld R, McGee R, Jackson R, Hughes R, Mulder R, Bonita R, Kruger R, Casswell S, Derrett S, Ameratunga S, Denny S, Hales S, Pullon S, Wells S, Cundy T, Blakely T.

N Z Med J. 2017 Feb 17;130(1450):94-101.

PMID:
28207729
20.

Urban Rural Differences in Breast Cancer in New Zealand.

Lawrenson R, Lao C, Elwood M, Brown C, Sarfati D, Campbell I.

Int J Environ Res Public Health. 2016 Oct 11;13(10). pii: E1000.

21.

Bioelectromagnetics Research within an Australian Context: The Australian Centre for Electromagnetic Bioeffects Research (ACEBR).

Loughran SP, Al Hossain MS, Bentvelzen A, Elwood M, Finnie J, Horvat J, Iskra S, Ivanova EP, Manavis J, Mudiyanselage CK, Lajevardipour A, Martinac B, McIntosh R, McKenzie R, Mustapic M, Nakayama Y, Pirogova E, Rashid MH, Taylor NA, Todorova N, Wiedemann PM, Vink R, Wood A, Yarovsky I, Croft RJ.

Int J Environ Res Public Health. 2016 Sep 29;13(10). pii: E967. Review.

22.

Stage of breast cancer at diagnosis in New Zealand: impacts of socio-demographic factors, breast cancer screening and biology.

Seneviratne S, Lawrenson R, Harvey V, Ramsaroop R, Elwood M, Scott N, Sarfati D, Campbell I.

BMC Cancer. 2016 Feb 19;16:129. doi: 10.1186/s12885-016-2177-5.

23.

Cost-effectiveness of annual versus biennial screening mammography for women with high mammographic breast density.

Pataky R, Ismail Z, Coldman AJ, Elwood M, Gelmon K, Hedden L, Hislop G, Kan L, McCoy B, Olivotto IA, Peacock S.

J Med Screen. 2014 Dec;21(4):180-8. doi: 10.1177/0969141314549758. Epub 2014 Sep 3.

PMID:
25186116
24.

Missed melanomas - comment.

Oakley A, Rademaker M, Elwood M.

N Z Med J. 2014 Jul 18;127(1398):141-2. No abstract available.

PMID:
25146874
25.

Cancer mortality and incidence trends comparing New Zealand and Australia for the period 2000-2007.

Alafeishat L, Elwood M, Ioannides S.

N Z Med J. 2014 Aug 15;127(1400):9-19.

PMID:
25145363
26.

Increases in disease in Malayan war veterans' children may be misleading.

Elwood M, Borman B.

N Z Med J. 2012 Dec 14;125(1367):145-6. No abstract available.

PMID:
23321895
27.

Association between melanoma thickness, clinical skin examination and socioeconomic status: results of a large population-based study.

Youl PH, Baade PD, Parekh S, English D, Elwood M, Aitken JF.

Int J Cancer. 2011 May 1;128(9):2158-65. doi: 10.1002/ijc.25540.

28.

A nationwide population-based skin cancer screening in Germany: proceedings of the first meeting of the International Task Force on Skin Cancer Screening and Prevention (September 24 and 25, 2009).

Geller AC, Greinert R, Sinclair C, Weinstock MA, Aitken J, Boniol M, Capellaro M, Doré JF, Elwood M, Fletcher SW, Gallagher R, Gandini S, Halpern AC, Katalinic A, Lucas R, Marghoob AA, Nolte S, Schüz J, Tucker MA, Volkmer B, Breitbart E.

Cancer Epidemiol. 2010 Jun;34(3):355-8. doi: 10.1016/j.canep.2010.03.006. Epub 2010 Apr 8.

PMID:
20381443
29.

Critical factors influencing the establishment, maintenance and sustainability of population-based cancer control programs.

Trapido EJ, Borras JM, Burton R, Samiei M, Elwood M; ICCC-3 Session F Group.

Tumori. 2009 Sep-Oct;95(5):637-45.

PMID:
19999953
30.

Clinical whole-body skin examination reduces the incidence of thick melanomas.

Aitken JF, Elwood M, Baade PD, Youl P, English D.

Int J Cancer. 2010 Jan 15;126(2):450-8. doi: 10.1002/ijc.24747.

31.

Occupational physical activity and risk of malignant melanoma: the Western Canada Melanoma Study.

Lee TK, MacArthur AC, Gallagher RP, Elwood MJ.

Melanoma Res. 2009 Aug;19(4):260-6. doi: 10.1097/CMR.0b013e32832e0bae.

PMID:
19531966
32.

Perceived impact on clinical practice and logistical issues in clinical management surveys of cancer: Australian experience.

Staples M, Elwood M, St John J, Howes F, Pedersen K.

Qual Saf Health Care. 2009 Jun;18(3):195-8. doi: 10.1136/qshc.2007.024398.

PMID:
19468001
33.

Factors related to the presentation of thin and thick nodular melanoma from a population-based cancer registry in Queensland Australia.

Geller AC, Elwood M, Swetter SM, Brooks DR, Aitken J, Youl PH, Demierre MF, Baade PD.

Cancer. 2009 Mar 15;115(6):1318-27. doi: 10.1002/cncr.24162.

34.

Cancer education and training in primary health care--a national audit of training providers.

McAvoy BR, Fletcher JM, Elwood M.

Aust Fam Physician. 2007 Nov;36(11):973-6.

35.

Diagnosis and management costs of suspicious skin lesions from a population-based melanoma screening programme.

Gordon L, Youl PH, Elwood M, Janda M, Ring IT, Lowe JB, Aitken JF.

J Med Screen. 2007;14(2):98-102.

PMID:
17626710
36.
37.

Cancer control policy in Australia.

Anderiesz C, Elwood M, Hill DJ.

Aust New Zealand Health Policy. 2006 Oct 23;3:12.

38.

What motivates men age > or =50 years to participate in a screening program for melanoma?

Janda M, Youl PH, Lowe JB, Baade PD, Elwood M, Ring IT, Aitken JF.

Cancer. 2006 Aug 15;107(4):815-23.

39.

Presentation and detection of invasive melanoma in a high-risk population.

McPherson M, Elwood M, English DR, Baade PD, Youl PH, Aitken JF.

J Am Acad Dermatol. 2006 May;54(5):783-92.

PMID:
16635658
40.

Who attends skin cancer clinics within a randomized melanoma screening program?

Youl PH, Janda M, Elwood M, Lowe JB, Ring IT, Aitken JF.

Cancer Detect Prev. 2006;30(1):44-51. Epub 2006 Feb 2.

PMID:
16457967
41.

Do centralised skin screening clinics increase participation in melanoma screening (Australia)?

Janda M, Lowe JB, Elwood M, Ring IT, Youl PH, Aitken JF.

Cancer Causes Control. 2006 Mar;17(2):161-8.

PMID:
16425094
42.

Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985.

Staples MP, Elwood M, Burton RC, Williams JL, Marks R, Giles GG.

Med J Aust. 2006 Jan 2;184(1):6-10.

PMID:
16398622
43.

Clinical outcomes from skin screening clinics within a community-based melanoma screening program.

Aitken JF, Janda M, Elwood M, Youl PH, Ring IT, Lowe JB.

J Am Acad Dermatol. 2006 Jan;54(1):105-14. Epub 2005 Nov 28.

PMID:
16384764
44.

Prostate cancer, the PSA test and academic detailing in Australian general practice: an economic evaluation.

Stone CA, May FW, Pinnock CB, Elwood M, Rowett DS.

Aust N Z J Public Health. 2005 Aug;29(4):349-57.

PMID:
16222933
45.

Increase in skin cancer screening during a community-based randomized intervention trial.

Aitken JF, Youl PH, Janda M, Lowe JB, Ring IT, Elwood M.

Int J Cancer. 2006 Feb 15;118(4):1010-6.

46.

Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.

Manser R, Dalton A, Carter R, Byrnes G, Elwood M, Campbell DA.

Lung Cancer. 2005 May;48(2):171-85. Epub 2005 Jan 4.

PMID:
15829317
47.

Cancer in Australia--an update for GPs.

McAvoy B, Elwood M, Staples M.

Aust Fam Physician. 2005 Jan-Feb;34(1-2):41-5.

PMID:
15727357
48.

Overview of observational studies of low-dose helical computed tomography screening for lung cancer.

Manser RL, Irving LB, de Campo MP, Abramson MJ, Stone CA, Pedersen KE, Elwood M, Campbell DA.

Respirology. 2005 Jan;10(1):97-104. Review.

PMID:
15691245
49.

Workgroup III: facilitating screening for colorectal cancer: quality assurance and evaluation. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002).

Patnick J, Ransohoff D, Atkin W, Borras JM, Elwood M, Hoff G, Nadel M, Russo A, Simon J, Weiderpass E, Zappa M, Smith R.

Ann Oncol. 2005 Jan;16(1):34-7. No abstract available. Erratum in: Ann Oncol. 2005 Jun;16(6):993. Weiderpass-Vaino, E [corrected to Weiderpass, E].

50.

A misleading paper on prostate cancer screening.

Elwood M.

Prostate. 2004 Dec 1;61(4):372; author reply 373-4. No abstract available.

PMID:
15503318

Supplemental Content

Loading ...
Support Center